- Home
- A-Z Publications
- Current Drug Targets
- Previous Issues
- Volume 23, Issue 16, 2022
Current Drug Targets - Volume 23, Issue 16, 2022
Volume 23, Issue 16, 2022
-
-
Long Non-coding RNA Therapeutics: Recent Advances and Challenges
Authors: Anjali Sangeeth, Mahesh Malleswarapu, Amit Mishra and Ravi K. GuttiThe discovery of the roles of RNA other than just as a messenger, such as a ribozyme, and regulatory RNAs, such as microRNA and long noncoding RNAs, is fascinating. RNA is now recognized as an important regulator involved in practically every biological process. Research in the field of non-coding RNAs, specifically microRNAs (miRNAs) and long non-coding RNAs (LncRNAs) have developed immensely over the years. Recent Read More
-
-
-
Therapeutic Approaches for Combating Aspergillus Associated Infection
Authors: Aruna Punia, Pooja Choudhary, Namita Sharma, Sweety Dahiya, Prity Gulia and Anil K. ChhillarNow-a-days fungal infection emerges as a significant problem to healthcare management systems due to high frequency of associated morbidity, mortality toxicity, drug-drug interactions, and resistance of the antifungal agents. Aspergillus is the most common mold that cause infection in immunocompromised hosts. It's a hyaline mold that is cosmopolitan and ubiquitous in nature. Aspergillus infects around 10 million popul Read More
-
-
-
Cellular Therapeutics for Chronic Wound Healing: Future for Regenerative Medicine
Authors: Preety Sharma, Arun Kumar and Asmita D. DeyChronic wounds are associated with significant morbidity and mortality, which demand long-term effective treatment and represent a tremendous financial strain on the global healthcare systems. Regenerative medicines using stem cells have recently become apparent as a promising approach and are an active zone of investigation. They hold the potential to differentiate into specific types of cells and thus possess self Read More
-
-
-
Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms
Authors: Chaofeng Xu, Zhongtu Shang and Masoud NajafiFibrosis and pneumonitis are the most important side effects of lung tissue following cancer therapy. Radiotherapy and chemotherapy by some drugs, such as bleomycin, can induce pneumonitis and fibrosis. Targeted therapy and immunotherapy also may induce pneumonitis and fibrosis to a lesser extent compared to chemotherapy and radiotherapy. Activation of lymphocytes by immunotherapy or infiltration of inflammato Read More
-
-
-
Targeted Mitochondrial Drugs for Treatment of Ischemia-Reperfusion Injury
Authors: Jin-Fu Peng, Oluwabukunmi M. Salami, Olive Habimana, Yu-Xin Xie, Hui Yao and Guang-Hui YiIschemia-reperfusion injury is a complex hemodynamic pathology that is a leading cause of death worldwide and occurs in many body organs. Numerous studies have shown that mitochondria play an important role in the occurrence mechanism of ischemia-reperfusion injury and that mitochondrial structural abnormalities and dysfunction lead to the disruption of the homeostasis of the whole mitochondria. At this time, Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdt
Journal
10
5
false
en
